InCrowd and Survey Healthcare Global are now part of Konovo

Medical Marijuana

Report: Medical Marijuana & Palliative Care—Prescriber & Patient Perspectives

Download the report or watch the recording presented by Daniel S. Fitzgerald, CEO, and Meghan Oates-Zalesky, CMO, of Apollo Intelligence. 

In 2018, less than a third of US oncologists believed they were informed enough to make recommendations to patients regarding medical marijuana, according to a study conducted by the Journal of Clinical Oncology. Five years later, the Apollo team wanted to understand if prescriber confidence had grown and how patients with chronic pain perceived medical marijuana as a palliative alternative.

  • The adoption of medical marijuana across the U.S. and Europe
  • The considerations affecting patients as they address chronic pain management and the options available to them
  • Physicians’ positions on prescribing medical marijuana for palliative treatment

Get the Report

You may also be interested in:

The Next Generation of Intelligent Tracker Studies: Faster, Smarter, More Actionable

Traditional tracker studies can’t keep pace with today’s rapidly shifting healthcare markets — by the time results arrive, the landscape has already changed. To stay relevant, trackers must evolve into...
Keep Reading
AI in qualitative research

Now is the Time to Embrace AI in Qualitative Research

As AI continues to advance at a rapid pace, it’s quickly shifting from an experimental tool to a core component of business workflows – helping research teams move faster without...
Keep Reading
A doctor wearing a white lab coat and a stethoscope around the neck is holding and looking at a blue smartphone. The doctor's face is partially visible, and the background shows large windows with blurred outdoor scenery

Why Healthcare Research Needs to Change

The way care is delivered is changing fast. Virtual visits, accelerated approvals, shifting policies, and rising provider burnout are making it harder to reach the right healthcare providers (HCPs)—and harder...
Keep Reading